Bank of America Corp DE Has $152,000 Holdings in Aemetis, Inc. (NASDAQ:AMTX)

Bank of America Corp DE lifted its stake in shares of Aemetis, Inc. (NASDAQ:AMTX) by 37.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 56,675 shares of the specialty chemicals company’s stock after buying an additional 15,533 shares during the period. Bank of America Corp DE owned about 0.11% of Aemetis worth $152,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of AMTX. Voya Investment Management LLC acquired a new position in shares of Aemetis during the fourth quarter worth $28,000. Tower Research Capital LLC TRC increased its holdings in Aemetis by 128.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 10,407 shares of the specialty chemicals company’s stock valued at $28,000 after purchasing an additional 5,859 shares during the period. Intech Investment Management LLC acquired a new stake in Aemetis in the fourth quarter valued at $46,000. Price T Rowe Associates Inc. MD increased its holdings in Aemetis by 16.1% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 38,016 shares of the specialty chemicals company’s stock valued at $103,000 after purchasing an additional 5,281 shares during the period. Finally, Wells Fargo & Company MN increased its holdings in Aemetis by 20.0% in the fourth quarter. Wells Fargo & Company MN now owns 45,741 shares of the specialty chemicals company’s stock valued at $123,000 after purchasing an additional 7,622 shares during the period. 27.02% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on AMTX shares. Ascendiant Capital Markets increased their price objective on Aemetis from $19.00 to $20.00 and gave the company a “buy” rating in a report on Friday, June 6th. UBS Group decreased their price objective on Aemetis from $2.50 to $2.20 and set a “buy” rating for the company in a report on Friday, May 9th. Finally, HC Wainwright restated a “buy” rating and issued a $28.00 price objective on shares of Aemetis in a report on Friday, March 14th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $13.43.

Aemetis Trading Up 10.9%

Shares of Aemetis stock opened at $2.14 on Tuesday. The business has a 50-day moving average price of $1.59 and a two-hundred day moving average price of $2.07. Aemetis, Inc. has a 1-year low of $1.22 and a 1-year high of $4.73. The company has a market cap of $118.49 million, a P/E ratio of -0.95 and a beta of 1.48.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings results on Thursday, May 8th. The specialty chemicals company reported ($0.47) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.08). The business had revenue of $42.89 million during the quarter, compared to analysts’ expectations of $59.35 million. During the same period in the prior year, the firm posted ($0.58) EPS. Equities research analysts forecast that Aemetis, Inc. will post -2.07 EPS for the current fiscal year.

Aemetis Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.